Work

A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids

Year: 2021
Type: article
Abstract: Developing effective drugs for Alzheimer's disease (AD), the most common cause of dementia, has been difficult because of complicated pathogenesis. Here, we report an efficient, network-based drug-screening platform developed by integrating mathematical modeling and the pathological features of AD with human iPSC-derived cerebral organoids (iCOs), including CRISPR-Cas9-edited isogenic lines. We use 1300 organoids from 11 participants to build a high-content screening (HCS) system and test blood-brain barrier-permeable FDA-approved drugs. Our study provides a strategy for precision medicine through the convergence of mathematical modeling and a miniature pathological brain model using iCOs.
Language: English
Open Access status: gold
Estimated APC paid: $5,560
OpenAlex ID: W3118278361
FWCI: 12.63
Cites: 80
Cited by: 247
Related to: 9